IN8bio, Inc. (INAB) NASDAQ

1.82

+0.07(+4.00%)

Updated at December 04 04:00PM

Currency In USD

Valuation

Market Cap413.38M
Enterprise Value407.29M
P/E Ratio-0.4
PEG Ratio0.01
Price/Sales Ratio3.36
Price/Book Ratio0.63
Enterprise/Revenue0.3
Enterprise/EBITDA-0.04

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-8.18
Operating Margin-8.2

Management Effectiveness

Return On Assets-1.23
Return On Equity-1.46

Income Statement

Revenue0
Revenue/Share0.56
Gross Profit0
EBITDA-26.94M
Net Income-30.44M
Diluted EPS-0.57

Balance Sheet

Total Cash10.69M
Total Cash/Share2.36
Total Debt2.96M
Total Debt/Equity0.22
Current Ratio6.91
Book Value Per Share2.91

Price History

52-Week Change-79.87
52-Week High12.54
52-Week Low1.53
Moving Average 50 Days1.98
Moving Average 200 Days3.46

Statistics

Average Volume70,690
Shares Outstanding4.63M
% Held by Institutions0.01

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:30
Last Split DateJune 06, 2025